Approved Symbol |
Approved Name |
Location |
No. of Studies (Positive/Negative/Trend)  |
Evidence[PMID] |
CACNB2 |
calcium channel, voltage-dependent, beta 2 subunit |
10p12 |
3(2/1/0)
|
IBA
|
PRKACB |
protein kinase, cAMP-dependent, catalytic, beta |
1p36.1 |
1(0/1/0)
|
TAS
|
VAMP2 |
vesicle-associated membrane protein 2 (synaptobrevin 2) |
17p13.1 |
1(1/0/0)
|
TAS
|
SSTR1 |
somatostatin receptor 1 |
14q13 |
1(1/0/0)
|
IBA
|
SST |
somatostatin |
3q28 |
1(0/1/0)
|
TAS[9437026]
|
DRD4 |
dopamine receptor D4 |
11p15.5 |
13(1/12/0)
|
IBA
|
HTR3B |
5-hydroxytryptamine (serotonin) receptor 3B, ionotropic |
11q23.1 |
2(1/1/0)
|
TAS[9950429]
|
GRIA1 |
glutamate receptor, ionotropic, AMPA 1 |
5q33 |
2(2/0/0)
|
TAS
|
NRXN1 |
neurexin 1 |
2p16.3 |
1(1/0/0)
|
ISS
|
GNAL |
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type |
18p11.22-p11.21 |
2(0/2/0)
|
TAS
|
KCNN3 |
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3 |
1q21.3 |
7(1/6/0)
|
TAS
|
CHAT |
choline O-acetyltransferase |
10q11.2 |
1(0/1/0)
|
TAS
|
GRM3 |
glutamate receptor, metabotropic 3 |
7q21.1-q21.2 |
7(3/4/0)
|
TAS[8840013]
|
KCNQ2 |
potassium channel, voltage gated KQT-like subfamily Q, member 2 |
20q13.33 |
1(1/0/0)
|
TAS
|
DLG3 |
discs, large homolog 3 (Drosophila) |
Xq13.1 |
1(0/1/0)
|
IBA; TAS
|
DRD5 |
dopamine receptor D5 |
4p16.1 |
2(0/2/0)
|
NAS[7727453]
|
GABRB2 |
gamma-aminobutyric acid (GABA) A receptor, beta 2 |
5q34 |
1(1/0/0)
|
TAS
|
GRIP1 |
glutamate receptor interacting protein 1 |
12q13.13 |
1(1/0/0)
|
TAS
|
HTR7 |
5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled |
10q21-q24 |
2(0/2/0)
|
IEA
|
CHRNB2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) |
1q21.3 |
1(1/0/0)
|
TAS
|
SLC18A2 |
solute carrier family 18 (vesicular monoamine transporter), member 2 |
10q25 |
1(1/0/0)
|
TAS[15217342]
|
GRIA3 |
glutamate receptor, ionotropic, AMPA 3 |
Xq25 |
1(0/1/0)
|
TAS
|
CACNG2 |
calcium channel, voltage-dependent, gamma subunit 2 |
22q13.1 |
3(3/0/0)
|
TAS
|
MAOA |
monoamine oxidase A |
Xp11.4-p11.3 |
21(10/11/0)
|
TAS
|
PICK1 |
protein interacting with PRKCA 1 |
22q13.1 |
1(0/1/0)
|
TAS
|
CHRNA3 |
cholinergic receptor, nicotinic, alpha 3 (neuronal) |
15q24 |
3(1/2/0)
|
TAS
|
GABRA1 |
gamma-aminobutyric acid (GABA) A receptor, alpha 1 |
5q34 |
2(1/1/0)
|
TAS
|
GAD1 |
glutamate decarboxylase 1 (brain, 67kDa) |
2q31 |
2(1/1/0)
|
TAS
|
RASGRF2 |
Ras protein-specific guanine nucleotide-releasing factor 2 |
5q13 |
1(0/0/1)
|
TAS
|
GNAI2 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
3p21.31 |
1(0/1/0)
|
TAS
|
GRM7 |
glutamate receptor, metabotropic 7 |
3p26-p25 |
3(2/1/0)
|
IDA[9473604]
|
CHRNA9 |
cholinergic receptor, nicotinic, alpha 9 (neuronal) |
4p14 |
2(0/2/0)
|
TAS
|
GABRA6 |
gamma-aminobutyric acid (GABA) A receptor, alpha 6 |
5q34 |
1(0/1/0)
|
TAS
|
GRIK4 |
glutamate receptor, ionotropic, kainate 4 |
11q23.3 |
2(1/1/0)
|
TAS
|
GABRR1 |
gamma-aminobutyric acid (GABA) A receptor, rho 1 |
6q15 |
1(1/0/0)
|
TAS
|
CARTPT |
CART prepropeptide |
5q13.2 |
1(0/1/0)
|
IEA
|
ADCY9 |
adenylate cyclase 9 |
16p13.3 |
2(1/1/0)
|
TAS
|
GNB3 |
guanine nucleotide binding protein (G protein), beta polypeptide 3 |
12p13 |
2(1/1/0)
|
TAS
|
GRM2 |
glutamate receptor, metabotropic 2 |
3p21.2 |
1(0/1/0)
|
TAS[7620613]
|
CACNA1E |
calcium channel, voltage-dependent, R type, alpha 1E subunit |
1q25.3 |
1(1/0/0)
|
IBA; TAS
|
CACNB3 |
calcium channel, voltage-dependent, beta 3 subunit |
12q13 |
1(0/0/1)
|
IBA; TAS
|
KCNMB2 |
potassium channel subfamily M regulatory beta subunit 2 |
3q26.32 |
1(1/0/0)
|
IBA; TAS
|
GABRA4 |
gamma-aminobutyric acid (GABA) A receptor, alpha 4 |
4p12 |
2(2/0/0)
|
TAS
|
GRIK3 |
glutamate receptor, ionotropic, kainate 3 |
1p34.3 |
1(1/0/0)
|
TAS
|
NPFFR2 |
neuropeptide FF receptor 2 |
4q21 |
1(0/1/0)
|
IBA
|
CACNA1C |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
12p13.3 |
20(17/3/0)
|
IEA
|
GABRB1 |
gamma-aminobutyric acid (GABA) A receptor, beta 1 |
4p12 |
3(2/0/1)
|
TAS
|
CHRNB4 |
cholinergic receptor, nicotinic, beta 4 (neuronal) |
15q24 |
2(1/1/0)
|
TAS
|
CREB1 |
cAMP responsive element binding protein 1 |
2q34 |
2(1/1/0)
|
TAS
|
SYN2 |
synapsin II |
3p25.2 |
1(0/1/0)
|
TAS[8964517]
|
GRM4 |
glutamate receptor, metabotropic 4 |
6p21.3 |
2(2/0/0)
|
IEA
|
NEFL |
neurofilament, light polypeptide |
8p21.2 |
1(0/1/0)
|
TAS
|
GABRA3 |
gamma-aminobutyric acid (GABA) A receptor, alpha 3 |
Xq28 |
3(1/2/0)
|
TAS
|
MBP |
myelin basic protein |
18q23 |
1(1/0/0)
|
TAS[2434243]
|
SLC1A1 |
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
9p24 |
1(1/0/0)
|
TAS[7521911]
|
CHRNA2 |
cholinergic receptor, nicotinic, alpha 2 (neuronal) |
8p21 |
3(0/3/0)
|
TAS
|
SLC1A2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
11p13-p12 |
1(1/0/0)
|
TAS[7521911]
|
CHRNA5 |
cholinergic receptor, nicotinic, alpha 5 (neuronal) |
15q24 |
3(2/1/0)
|
TAS[9009220]
|
PNOC |
prepronociceptin |
8p21 |
1(0/1/0)
|
IEA
|
SYPL1 |
synaptophysin-like 1 |
7q22.2 |
1(1/0/0)
|
TAS[8034131]
|
FGF12 |
fibroblast growth factor 12 |
3q28 |
1(0/1/0)
|
IEA
|
HTR6 |
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled |
1p36-p35 |
3(1/2/0)
|
TAS[8522988]
|
NPTX1 |
neuronal pentraxin I |
17q25.3 |
2(1/1/0)
|
TAS[8884281]
|
NCALD |
neurocalcin delta |
8q22.3 |
1(0/1/0)
|
TAS
|
NRXN3 |
neurexin 3 |
14q31 |
2(2/0/0)
|
IEA
|
PPFIA1 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1 |
11q13.3 |
1(1/0/0)
|
TAS
|
ALDH2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
12q24.12 |
3(3/0/0)
|
TAS
|
HTR1F |
5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupled |
3p12 |
1(1/0/0)
|
TAS[8380639]
|
GABBR2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
9q22.1-q22.3 |
2(0/2/0)
|
TAS
|
TSPO |
translocator protein (18kDa) |
22q13.3 |
3(1/2/0)
|
IEA
|
CACNA1B |
calcium channel, voltage-dependent, N type, alpha 1B subunit |
9q34 |
1(1/0/0)
|
IBA; TAS
|
PMCH |
pro-melanin-concentrating hormone |
12q23.2 |
1(1/0/0)
|
IEA
|
GRIN2A |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
16p13.2 |
1(1/0/0)
|
TAS
|
KCNH7 |
potassium channel, voltage gated eag related subfamily H, member 7 |
2q24.3 |
3(2/0/1)
|
TAS
|
ADCY8 |
adenylate cyclase 8 (brain) |
8q24 |
4(2/1/1)
|
TAS
|
GRIK2 |
glutamate receptor, ionotropic, kainate 2 |
6q16.3 |
3(1/1/1)
|
TAS
|
COMT |
catechol-O-methyltransferase |
22q11.21 |
28(14/14/0)
|
TAS
|
GABRB3 |
gamma-aminobutyric acid (GABA) A receptor, beta 3 |
15q12 |
3(1/2/0)
|
TAS
|
GABRG3 |
gamma-aminobutyric acid (GABA) A receptor, gamma 3 |
15q12 |
1(0/1/0)
|
TAS
|
SLC6A3 |
solute carrier family 6 (neurotransmitter transporter), member 3 |
5p15.3 |
11(5/6/0)
|
TAS
|
GRIN2B |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
12p13.1 |
8(4/4/0)
|
TAS
|
CHRNA1 |
cholinergic receptor, nicotinic, alpha 1 (muscle) |
2q31.1 |
2(0/1/1)
|
TAS
|
GABRR3 |
gamma-aminobutyric acid (GABA) A receptor, rho 3 (gene/pseudogene) |
3q11.2 |
1(1/0/0)
|
NAS[10542332]; TAS
|
ADCY2 |
adenylate cyclase 2 (brain) |
5p15.3 |
2(1/1/0)
|
TAS
|
SSTR5 |
somatostatin receptor 5 |
16p13.3 |
2(1/1/0)
|
IBA
|
GRIN1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
9q34.3 |
3(2/1/0)
|
TAS
|
HTR1D |
5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled |
1p36.3-p34.3 |
1(0/1/0)
|
IEA
|
CHRNB3 |
cholinergic receptor, nicotinic, beta 3 (neuronal) |
8p11.21 |
3(1/2/0)
|
TAS
|
DLG2 |
discs, large homolog 2 (Drosophila) |
11q21 |
3(1/1/1)
|
IBA
|
HTR2C |
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled |
Xq23 |
7(4/3/0)
|
TAS[9241279]
|
SLC6A2 |
solute carrier family 6 (neurotransmitter transporter), member 2 |
16q12.2 |
2(0/2/0)
|
TAS[2008212]
|
GRIN2D |
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
19q13.33 |
1(1/0/0)
|
TAS
|
HTR3A |
5-hydroxytryptamine (serotonin) receptor 3A, ionotropic |
11q23.1-q23.2 |
2(1/1/0)
|
TAS[7565620]
|
SLC6A5 |
solute carrier family 6 (neurotransmitter transporter), member 5 |
11p15.1 |
1(0/1/0)
|
TAS[9845349]
|
KCNK10 |
potassium channel, two pore domain subfamily K, member 10 |
14q31 |
1(1/0/0)
|
TAS
|
HCRTR1 |
hypocretin (orexin) receptor 1 |
1p33 |
1(1/0/0)
|
TAS[9491897]
|
GAD2 |
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) |
10p13-p11.2 |
1(0/1/0)
|
TAS
|
HTR4 |
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled |
5q31-q33 |
2(1/1/0)
|
IEA
|
DBH |
dopamine beta-hydroxylase (dopamine beta-monooxygenase) |
9q34 |
3(1/2/0)
|
TAS[2880016]
|
GRIK5 |
glutamate receptor, ionotropic, kainate 5 |
19q13.2 |
2(1/0/1)
|
TAS
|
CAMK2A |
calcium/calmodulin-dependent protein kinase II alpha |
5q32 |
2(1/1/0)
|
TAS
|
DRD3 |
dopamine receptor D3 |
3q13.3 |
19(4/15/0)
|
IBA
|
CRH |
corticotropin releasing hormone |
8q13 |
2(1/1/0)
|
TAS[7477348]
|
DLG1 |
discs, large homolog 1 (Drosophila) |
3q29 |
2(1/1/0)
|
IBA; TAS
|
CHRNA7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) |
15q13.3 |
4(2/2/0)
|
TAS
|
SNCG |
synuclein, gamma (breast cancer-specific protein 1) |
10q23.2-q23.3 |
1(0/1/0)
|
IEA
|
KCNQ3 |
potassium channel, voltage gated KQT-like subfamily Q, member 3 |
8q24 |
4(3/0/1)
|
TAS
|
NRXN2 |
neurexin 2 |
11q13 |
1(1/0/0)
|
IEA; ISS
|
HTR1E |
5-hydroxytryptamine (serotonin) receptor 1E, G protein-coupled |
6q14-q15 |
1(0/1/0)
|
IEA
|
HCRTR2 |
hypocretin (orexin) receptor 2 |
6p12.1 |
1(1/0/0)
|
TAS[9491897]
|
CHRNA4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal) |
20q13.33 |
1(1/0/0)
|
NAS[7550350]; TAS
|
SNAP25 |
synaptosomal-associated protein, 25kDa |
20p12-p11.2 |
2(2/0/0)
|
NAS[8760387]; TAS
|
KCND2 |
potassium channel, voltage gated Shal related subfamily D, member 2 |
7q31 |
1(1/0/0)
|
TAS[11102480]
|
CHRNA6 |
cholinergic receptor, nicotinic, alpha 6 (neuronal) |
8p22 |
1(0/1/0)
|
TAS
|
HTR2A |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
13q14-q21 |
22(7/15/0)
|
TAS[9109547]
|
GABRA5 |
gamma-aminobutyric acid (GABA) A receptor, alpha 5 |
15q12 |
6(6/0/0)
|
TAS
|